IP Library › Granted Patent US 10,501,417
Granted Patent B2
US 10,501,417 · App. 16/097,065 · Granted Dec 10, 2019

Synthesis of indazoles

Inventors: Tobias Thaler (Köln, DE); Johannes Platzek (Berlin, DE); Nicolas Guimond (Wuppertal, DE)
Assignee: Bayer Pharma Aktiengesellschaft
C07D213/81C07D213/54C07D231/56C07D401/12C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,417
App. No.
16/097,065
Granted
Dec 10, 2019
Kind
B2
Abstract

The present invention relates to a novel method of preparing a 2-substituted indazole of structure: (I), to intermediate compounds, and to the use of intermediate compounds for the preparation of said 2-substituted indazole.

Claims (36)

1. A method of preparing a compound of formula (I):

comprising

reacting a compound of formula (V):

with a vinyl sulfone compound of formula (IX′):

wherein R is methyl, to provide the compound of formula (I).

2. The method according to claim 1 , wherein the compound of formula (V) is reacted with the compound of formula (IX′) in an aromatic hydrocarbon solvent.

3. The method according to claim 1 , further comprising

reacting a compound of formula (VI):

with a reductive methylating agent, to provide the compound of formula (V)

4. The method according to claim 3 , further comprising

reacting a compound of formula (VIII):

with a compound of formula (VII):

to provide the compound of formula (VI)

5. The method according to claim 4 ,

wherein the compound of formula (V) and the compound of formula (IX′) are reacted in an aromatic hydrocarbon solvent, and

wherein the reductive methylating agent is methylmagnesium chloride.

6. The method according to claim 5 ,

wherein the aromatic hydrocarbon solvent is toluene;

and

wherein the compound of formula (VI) is reacted with the reductive methylating agent in the presence of an alkali metal halide wherein the reductive methylating agent is methyl magnesium chloride and the alkali metal halide is lithium chloride.

7. The method according to claim 1 , wherein said compound of formula (I) is purified by crystallization.

8. The method according to claim 7 , wherein the compound of formula (I) is purified by crystallization from a solvent, and wherein said solvent is ethanol.

9. The method according to claim 7 , wherein the compound of formula (I) is purified by crystallization from a solvent, and wherein said solvent is isopropanol.

10. The method according to claim 1 , comprising reacting the compound of formula (V) with the compound of formula (IX′) in an aromatic hydrocarbon solvent at the reflux temperature of said solvent.

11. The method according to claim 3 , wherein the reductive methylating agent is a methylmetallic agent.

12. The method according to claim 11 , wherein the methylmetallic agent is a methylmagnesium halide.

13. The method according to claim 12 , wherein the methylmagnesium halide is methylmagnesium chloride.

14. The method according to claim 3 , comprising reacting the compound of formula (VI) with the reductive methylating agent in the presence of an alkali metal halide.

15. The method of claim 4 , comprising reacting the compound of formula (VIII) with the compound of formula (VII) in the presence of an organic base.

16. The method according to claim 15 , wherein the organic base is a weak organic base.

17. The method according to claim 16 , wherein the weak organic base is a tertiary amine.

18. The method according to claim 4 , comprising reacting the compound of formula (VIII) with the compound of formula (VII) in the presence of a coupling agent.

19. The method of claim 2 , wherein the aromatic hydrocarbon solvent is toluene.

20. The method of claim 14 , wherein the alkali metal halide is lithium chloride.

21. The method of claim 17 , wherein tertiary amine is N,N-diisopropylethylamine.

22. The method of claim 18 , wherein the coupling agent is 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (T3P).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2019
From: THALER, TOBIAS; PLATZEK, JOHANNES; GUIMOND, NICOLAS
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 048104/0525 →
Priority Claims (1)
EP 16167652 · Apr 29, 2016 · regional
Continuity (1)
Related Publication 20190106407A1 · Apr 11, 2019
Cited By (1)
US 12,559,473